Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy - ScienceDirect
Lipid-lowering medications: Fibrates | Osmosis
Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE*3-Leiden.CETP Mice* - Journal of Biological Chemistry
Fibrate pharmacogenomics: expanding past the genome | Pharmacogenomics
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism | Circulation
Management of Hyperlipoprotinaemia - ppt video online download
Fenofibrate in cancer: mechanisms involved in... | F1000Research
Molecular targets of fenofibrate in the cardiovascular-renal axis: A unifying perspective of its pleiotropic benefits - ScienceDirect
Structure and metabolic pathway for fenofibrate and fenofibric acid... | Download Scientific Diagram
Could fenofibrate be an effective antiviral against SARS-CoV-2?
Lipid Control Drugs | Concise Medical Knowledge
Fibrates - Gemfibrozil and Fenofibrate Mechanism: ... | GrepMed
The Mechanism of Action of Ezetimibe (Zetia) on the Inhibition of Cholesterol Absorption
Simplified PPARα dependent mechanism of action of fenofibrate on lipid... | Download Scientific Diagram
Lowering lipid mechanisms of fenofibrate. Fenifibrate activates PPARα,... | Download Scientific Diagram
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink
Figure 1 | Fenofibrate | SpringerLink
Potent and PPARα-independent anti-proliferative action of the hypolipidemic drug fenofibrate in VEGF-dependent angiosarcomas in vitro | Scientific Reports
Fenofibrate in cancer: mechanisms involved in... | F1000Research
Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study - Clinical Therapeutics
Cholesterol Lowering Drugs - Endotext - NCBI Bookshelf
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study - The Lancet Diabetes & Endocrinology
Fenofibrate improves vascular endothelial function and contractility in diabetic mice - ScienceDirect
Fenofibrate in cancer: mechanisms involved in... | F1000Research
Fenofibrate - Drugs Details
